Natriuretic Peptides and Metabolic Hypertension

Cardiac natriuretic peptides have become a biochemical mainstay in the assessment of chronic heart failure. Plasma measurement is now implemented in guidelines from both Europe and the United States, and their diagnostic role can, to some extent, be compared to the role of troponin measurement in acute myocardial infraction. Thus, molecules released by cardiomyocytes have key roles in our diagnostic approach to cardiovascular disease, whether it be cell death and necrosis or dynamic regulation and release.